Showing results (2581-2590 of 5,969) with videos related to
Sort By:
Pageof 597
Endocrine|August 12, 2022
Tumor mutation burden-assisted risk stratification for papillary thyroid cancerZhijiang Chen, Weiran Wang, Jiajie Xu, et al.Endocrine|November 11, 2022
Association between the history of abortion and gestational diabetes mellitus: A meta-analysisHao Wang, Xianwei Guo, Qiuxia Song, et al.Endocrine|November 12, 2022
Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosisSuman Ghosal, Katerina Hadrava Vanova, Ondrej Uher, et al.Endocrine|August 19, 2022
Comparison between total thyroidectomy and hemithyroidectomy in TIR3B thyroid nodules managementDomenico Albano, Giorgio Treglia, Francesco Dondi, et al.Endocrine|August 19, 2022
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the questionIrene Caramella, Alberto Dalla Volta, Marco Bergamini, et al.Endocrine|August 26, 2022
The association between Takotsubo cardiomyopathy and thyrotoxicosis: A systematic reviewAbdullahi Ahmed Mohamed, Tayfun Basaran, Marwan Hassan Othman, et al.Endocrine|August 26, 2022
Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodesZiyu Luo, Hu Hei, Jianwu Qin, et al.Endocrine|February 24, 2023
A proposed grading scheme for predicting recurrence in medullary thyroid cancer based on the Ki67 index and metastatic lymph node ratioPengfei Xu, Di Wu, Xuekui LiuEndocrine|March 3, 2023
Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective studyLingge Wu, Yan Xu, Xiang Wang, et al.Endocrine|March 20, 2023
Development and validation of a nomogram to estimate future risk of type 2 diabetes mellitus in adults with metabolic syndrome: prospective cohort studyTongyue Yang, Jiao Wang, Lina Wu, et al.Pageof 597